| abstract |
PROBLEM TO BE SOLVED: To provide a new therapeutic method for a patient with nicotine responsive neuropsychiatric disease. A nicotine responsive neuropsychiatric disorder can be treated by administering a nicotine antagonist, particularly mecamylamine. A combination therapy of mecamylamine and a neuroleptic is also disclosed. Neuropsychiatric disorders include Tourette syndrome, schizophrenia, gonorrhea, manic depression, tremor, attention deficit hyperactivity disorder, obsessive compulsive disorder, half-muscle tone abnormalities, furious outbreaks and late movement disorders Can be mentioned. [Selection figure] None |